What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Myocardial infarction
Internal medicine, Cardiology, Cholesterol, Atheroma and Coronary artery disease are his primary areas of study.
His study looks at the relationship between Internal medicine and topics such as Endocrinology, which overlap with Prospective cohort study.
His work in the fields of Cardiology, such as Coronary atherosclerosis and Intravascular ultrasound, intersects with other areas such as Asymmetric dimethylarginine.
His work in Atheroma addresses subjects such as Calcification, which are connected to disciplines such as Incidence.
His Coronary artery disease study combines topics in areas such as Diabetes mellitus, Atherosclerotic cardiovascular disease, Gastroenterology, Glycated hemoglobin and C-reactive protein.
His Statin study integrates concerns from other disciplines, such as Atorvastatin, Tolerability, Randomized controlled trial, Placebo and Rosuvastatin.
His most cited work include:
- Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. (1596 citations)
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome (1421 citations)
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. (1055 citations)
What are the main themes of his work throughout his whole career to date?
Stephen J. Nicholls focuses on Internal medicine, Cardiology, Coronary artery disease, Intravascular ultrasound and Coronary atherosclerosis.
His Internal medicine research is multidisciplinary, incorporating perspectives in Diabetes mellitus and Endocrinology.
As a part of the same scientific study, Stephen J. Nicholls usually deals with the Cardiology, concentrating on Rosuvastatin and frequently concerns with Statin.
His studies in Coronary artery disease integrate themes in fields like Atorvastatin and Vascular disease.
His Intravascular ultrasound research is multidisciplinary, incorporating perspectives in Coronary arteries and Pathology.
His Cholesterol study frequently draws connections to adjacent fields such as Disease.
He most often published in these fields:
- Internal medicine (69.64%)
- Cardiology (47.48%)
- Coronary artery disease (25.67%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (69.64%)
- Cardiology (47.48%)
- Coronary artery disease (25.67%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Coronary artery disease, In patient and Acute coronary syndrome.
Stephen J. Nicholls interconnects Diabetes mellitus and Placebo in the investigation of issues within Internal medicine.
His biological study spans a wide range of topics, including Lipoprotein and Computed tomography.
Stephen J. Nicholls mostly deals with Coronary atherosclerosis in his studies of Coronary artery disease.
The Acute coronary syndrome study which covers Type 2 diabetes that intersects with Heart failure.
His Cholesterol research is mostly focused on the topic Lipoprotein.
Between 2018 and 2021, his most popular works were:
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (373 citations)
- Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants with Risk of Coronary Heart Disease (209 citations)
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (135 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Myocardial infarction
Stephen J. Nicholls mostly deals with Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Acute coronary syndrome.
The concepts of his Internal medicine study are interwoven with issues in Diabetes mellitus, Type 2 diabetes and Placebo.
His study in the field of Coronary angiography also crosses realms of Spontaneous coronary artery dissection.
His research in Myocardial infarction intersects with topics in Stroke, Odds ratio and C-reactive protein.
His study on Coronary artery disease also encompasses disciplines like
- Angiography that connect with fields like Radiomics, Culprit and Coronary computed tomography angiography,
- Calcification, which have a strong connection to Very low-density lipoprotein, Pathogenesis, Proprotein convertase, Kexin and Statin.
In his research, Adverse effect, Randomized controlled trial and Revascularization is intimately related to Hazard ratio, which falls under the overarching field of Acute coronary syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
